Trials that use: Odds ratio
New to this method? Read the tutorial →
5,976 results
- NCT01009034Independent statistical analysis of Concentrations of Maraviroc in the Semen of HIV-Infected Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01009034).
- Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nebulized Hypertonic Saline for Mechanically Ventilated Children: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Hypertonic Saline for Mechanically Ventilated Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01945944).
- NefigardIndependent statistical analysis of Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Negative Beta Glucan in ICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Negative Beta Glucan in ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01734525).
- Neo ALTTOIndependent statistical analysis of Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553358).
- Neo TrioIndependent statistical analysis of Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: Complete Statistical AnalysisIndependent statistical analysis of Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04512430).
- Neo-Synalar Modified 48 Hour Patch Test: Complete Statistical AnalysisIndependent statistical analysis of Neo-Synalar Modified 48 Hour Patch Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02168478).
- Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03747120).
- Neoadjuvant Immunotherapy in Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunotherapy in Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04434560).
- Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04869137).
- Neoadjuvant Pazopanib in Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Pazopanib in Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01361113).
- Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: primary endpoint results, effect estimate…
- Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00828308).
- NeohttpIndependent statistical analysis of Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02345772).
- NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: Complete Statistical AnalysisIndependent statistical analysis of NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03522675).
- NEOMUNIndependent statistical analysis of Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03197467).
- Neonatal Outcome by Reason for Delivery: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Outcome by Reason for Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01818518).
- NEOTHROCOVIDIndependent statistical analysis of Thromboembolic Risk Screening in Patients With Cancer and COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04616846).
- Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: Complete Statistical AnalysisIndependent statistical analysis of Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nesiritide Use Following Cardiac Surgery in Infants: Complete Statistical AnalysisIndependent statistical analysis of Nesiritide Use Following Cardiac Surgery in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00281671).
- NEST-1Independent statistical analysis of Combination Immunotherapy in Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05571293).
- NeuHFRecoverIndependent statistical analysis of NMES in HF Patients to Improve Functional Recovery Following Hospitalization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05338437).
- Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery: Complete Statistical AnalysisIndependent statistical analysis of Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04017442).
- Neurodevelopmental Outcomes in Craniosynostosis Repair: Complete Statistical AnalysisIndependent statistical analysis of Neurodevelopmental Outcomes in Craniosynostosis Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04072783).
- Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders: Complete Statistical AnalysisIndependent statistical analysis of Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03398070).
- Neuropathic Pain Syndrome Patient Study (MK-0000-072): Complete Statistical AnalysisIndependent statistical analysis of Neuropathic Pain Syndrome Patient Study (MK-0000-072): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00570310).
- Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain: Complete Statistical AnalysisIndependent statistical analysis of Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- New Onset Type 1 Diabetes: Role of Exenatide: Complete Statistical AnalysisIndependent statistical analysis of New Onset Type 1 Diabetes: Role of Exenatide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01269034).
- New Treatment for Alcohol and Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of New Treatment for Alcohol and Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182766).
- NewHopeIndependent statistical analysis of Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NEwTON AFIndependent statistical analysis of Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NEXSCOTIndependent statistical analysis of Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Next Generation X-ray Imaging System: Complete Statistical AnalysisIndependent statistical analysis of Next Generation X-ray Imaging System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04571099).
- NF107-BMP2Independent statistical analysis of A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NFPIndependent statistical analysis of Nurse-Family Partnership Impact Evaluation in South Carolina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03360539).
- NGAM-05Independent statistical analysis of High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313507).
- NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation: Complete Statistical AnalysisIndependent statistical analysis of NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation: primary endpoint results, effect estimate…
- NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03929913).
- NIAGARAIndependent statistical analysis of Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P: Complete Statistical AnalysisIndependent statistical analysis of Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03369340).
- NIHO12Independent statistical analysis of Accuracy of Pulse Oximeters With Profound Hypoxia During Motion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04814342).
- NIKAIA 1Independent statistical analysis of To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus: primary endpoint results, effect estimate…
- NILOdeepRIndependent statistical analysis of Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…